Table 1: Counts, incidence rates, and annual percentage changes in rates for prostate cancer by demographic and clinical characteristics, US men, 2001–2007.

Count%Rate195% CIAPC95% CI

Total21,310,373100.0149.8149.6150.1−1.6−3.8 0.7
 <407000. 6.6 0.7 12.7
 40–4935,6482.723.923.724.2 3.0 0.6 5.5
 50–59257,12019.6221.0220.2221.9 0.0 −2.4 2.5
 60–69475,62536.3693.7691.7695.6−0.8−3.3 1.7
 White1,080,74282.5141.2140.9141.5−1.9−4.2 0.4
 Non-Spanish-Hispanic-Latino1,236,97894.4152.3152.0152.5−1.4−3.7 0.9
 Northeast297,14022.7162.2161.6162.8−1.4−4.7 2.1
 Midwest322,54424.6152.2151.7152.8−1.7−3.6 0.1
 South412,86231.5143.8143.4144.3−1.3−3.7 1.2
 Localized1,061,74881.0121.4121.1121.6−1.0−3.2 1.3
 Regional126,1429.613.613.613.7 0.2 −1.8 2.3
 Well differentiated25,5582.−26.0−27.3−24.8
 Moder/poor/undifferentiated1,233,81094.2140.7140.5141.0−0.5−2.4 1.5

AIAN: American Indian/Alaska Native, APC: annual percentage change, API: Asian/Pacific Islander, CI: confidence interval, moder/poor/undifferentiated: moderately, poorly, or undifferentiated.
1Rates are per 100,000 men and are age-adjusted to the 2000 US standard population.
2Data are from 46 population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and/or the Surveillance, Epidemiology, and End Results (SEER) Program and meet high quality data criteria. These registries cover 93.5% US population for 2001–2007.
3Unknown race and race groups other than white, black, AIAN, and API are not listed but included in the total case count.
4Hispanic origin is not mutually exclusive from race categories (white, black, AIAN, and API).
5Sum of counts is less than total due to missing information on stage.
~ indicates that the denominator for the rate was unknown.